Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Subscribe

Sci. Signal., 17 June 2008
Vol. 1, Issue 24, p. pe30
[DOI: 10.1126/scisignal.124pe30]

PERSPECTIVES

pVHL: A Multipurpose Adaptor Protein

Ian J. Frew and Wilhelm Krek*

Institute of Cell Biology, Eidgenössische Technische Hochschule (ETH) Zurich, 8093 Zurich, Switzerland.

Abstract: Mutations in the von Hippel-Lindau tumor suppressor gene VHL occur in various inherited and sporadically occurring tumors. The protein encoded by VHL—pVHL—bears no known enzymatic activities but interacts with numerous protein partners. With the identification of distinct pVHL-containing multiprotein complexes, a refined portrait of pVHL tumor suppressor function has arisen. In general, pVHL acts as a multipurpose adaptor protein that controls a diverse array of gene expression programs, as well as extracellular matrix assembly and microtubule-based processes, by linking various target proteins to appropriate enzymatic activities. These findings provide an evermore complex but coherent view of how pVHL functions molecularly and of the consequences of dysregulation of these diverse molecular activities on tumor formation.

*Corresponding author. Institute of Cell Biology, ETH Zurich, 8093 Zurich, Switzerland. Telephone, +41 44 633 3447; fax, +41 44 633 1357; e-mail, wilhelm.krek{at}cell.biol.ethz.ch

Citation: I. J. Frew, W. Krek, pVHL: A Multipurpose Adaptor Protein. Sci. Signal. 1, pe30 (2008).

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Spontaneous Peripheral T-cell Responses toward the Tumor-Associated Antigen Cyclin D1 in Patients with Clear Cell Renal Cell Carcinoma.
S. R. Dannenmann, T. Hermanns, A. Bransi, C. Matter, L. von Boehmer, S. Stevanovic, P. Schraml, H. Moch, A. Knuth, and M. van den Broek (2013)
Cancer Immunology 1, 288-295
   Abstract »    Full Text »    PDF »
HIF expression and the role of hypoxic microenvironments within primary tumours as protective sites driving cancer stem cell renewal and metastatic progression.
B. Philip, K. Ito, R. Moreno-Sanchez, and S. J. Ralph (2013)
Carcinogenesis 34, 1699-1707
   Abstract »    Full Text »    PDF »
The von Hippel-Lindau Protein pVHL Inhibits Ribosome Biogenesis and Protein Synthesis.
W.-T. Zhao, C.-F. Zhou, X.-B. Li, Y.-F. Zhang, L. Fan, J. Pelletier, and J. Fang (2013)
J. Biol. Chem. 288, 16588-16597
   Abstract »    Full Text »    PDF »
HIF1{alpha} and pancreatic {beta}-cell development.
M. Heinis, A. Soggia, C. Bechetoille, M.-T. Simon, C. Peyssonnaux, P. Rustin, R. Scharfmann, and B. Duvillie (2012)
FASEB J 26, 2734-2742
   Abstract »    Full Text »    PDF »
Drosophila Mgr, a Prefoldin subunit cooperating with von Hippel Lindau to regulate tubulin stability.
N. Delgehyr, U. Wieland, H. Rangone, X. Pinson, G. Mao, N. S. Dzhindzhev, D. McLean, M. G. Riparbelli, S. Llamazares, G. Callaini, et al. (2012)
PNAS 109, 5729-5734
   Abstract »    Full Text »    PDF »
VHL Gene Mutations and Their Effects on Hypoxia Inducible Factor HIF{alpha}: Identification of Potential Driver and Passenger Mutations.
M. P. Rechsteiner, A. von Teichman, A. Nowicka, T. Sulser, P. Schraml, and H. Moch (2011)
Cancer Res. 71, 5500-5511
   Abstract »    Full Text »    PDF »
Quantitative image analysis identifies pVHL as a key regulator of microtubule dynamic instability.
C. R. Thoma, A. Matov, K. L. Gutbrodt, C. R. Hoerner, Z. Smole, W. Krek, and G. Danuser (2010)
J. Cell Biol. 190, 991-1003
   Abstract »    Full Text »    PDF »
Loss of Hypoxia-Inducible Factor Prolyl Hydroxylase Activity in Cardiomyocytes Phenocopies Ischemic Cardiomyopathy.
J. Moslehi, Y. A. Minamishima, J. Shi, D. Neuberg, D. M. Charytan, R. F. Padera, S. Signoretti, R. Liao, and W. G. Kaelin Jr (2010)
Circulation 122, 1004-1016
   Abstract »    Full Text »    PDF »
Oxygen-Regulated {beta}2-Adrenergic Receptor Hydroxylation by EGLN3 and Ubiquitylation by pVHL.
L. Xie, K. Xiao, E. J. Whalen, M. T. Forrester, R. S. Freeman, G. Fong, S. P. Gygi, R. J. Lefkowitz, and J. S. Stamler (2009)
Science Signaling 2, ra33
   Abstract »    Full Text »    PDF »
Zebrafish mutants in the von Hippel-Lindau tumor suppressor display a hypoxic response and recapitulate key aspects of Chuvash polycythemia.
E. van Rooijen, E. E. Voest, I. Logister, J. Korving, T. Schwerte, S. Schulte-Merker, R. H. Giles, and F. J. van Eeden (2009)
Blood 113, 6449-6460
   Abstract »    Full Text »    PDF »

To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882